FDA Approves Vera Therapeutics’ Trutakna for Rare Kidney Disease, Marks New Era in Immunoglobulin A Nephropathy Treatment The U.S. Food and Drug Administration (FDA) approved Vera Therapeutics’ Trutakna on April …
nephrology
-
-
Finerenone Shows Promise in Treating Chronic Kidney Disease Without Diabetes, Study Finds Finerenone, a non-steroidal mineralocorticoid receptor antagonist, has demonstrated significant benefits in reducing the risk of kidney function decline …
-
Common Hypertension Drugs and Kidney Outcomes in Type 2 Diabetes Patients: What the Latest Research Shows Recent studies have raised concerns about the long-term effects of certain hypertension medications on …
-
Q1 2026 Earnings Calendar: Key Conference Calls for Hansa Biopharma, RenaissanceRe, and Stella-Jones As the first quarter of 2026 concludes, investors and analysts are turning their attention to upcoming financial …
-
Understanding Hemodialysis, Kidney Transplants, and Treatment Options for Kidney Failure Kidney failure occurs when the kidneys are no longer able to effectively filter waste and excess fluids from the blood. …
-
Kidney Test Mismatch Linked to Higher Risk of Disease and Death Table of Contents Kidney Test Mismatch Linked to Higher Risk of Disease and Death A gap that predicts future …